Day Return
YTD Return
1-Year Return
3-Year Return
5-Year Return
Note: Sector performance is calculated based on the previous closing price of all sector constituents
Industries in This Sector
Select an Industry for a Visual Breakdown
| Industry | Market Weight | YTD Return | |
|---|---|---|---|
| All Industries | 100.00% | 5.80% | |
| Drug Manufacturers - General | 34.03% | 11.51% | |
| Healthcare Plans | 13.21% | -2.59% | |
| Medical Devices | 12.68% | 5.59% | |
| Diagnostics & Research | 11.71% | 8.42% | |
| Biotechnology | 11.49% | -0.94% | |
| Medical Instruments & Supplies | 6.63% | 5.91% | |
| Medical Care Facilities | 2.91% | 13.46% | |
| Drug Manufacturers - Specialty & Generic | 2.75% | -2.68% | |
| Medical Distribution | 2.32% | 9.60% | |
| Health Information Services | 2.03% | 5.48% | |
| Pharmaceutical Retailers | 0.24% | -29.84% | |
Note: Percentage % data on heatmap indicates Day Return
All Industries
-
Largest Companies in This Sector
Name | Last Price | 1Y Target Est. | Market Weight | Market Cap | Day Change % | YTD Return | Avg. Analyst Rating |
|---|---|---|---|---|---|---|---|
| 777.84 | 858.83 | 11.26% | Buy | ||||
| 522.82 | 567.48 | 7.33% | Buy | ||||
| 152.45 | 172.72 | 5.59% | Buy | ||||
| 131.38 | 141.42 | 5.07% | Buy | ||||
| 165.55 | 182.41 | 4.45% | Buy | ||||
| 595.19 | 624.17 | 3.46% | Buy | ||||
| 267.30 | 271.39 | 3.02% | Buy | ||||
| 103.58 | 126.23 | 2.75% | Buy | ||||
| 315.07 | 316.85 | 2.58% | Buy | ||||
| 28.64 | 31.48 | 2.47% | Buy |
Investing in the Healthcare Sector
Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds
ETF Opportunities
Name | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| 146.22 | 37.936B | 0.09% | ||
| 267.10 | 20.002B | 0.10% | ||
| 137.14 | 6.991B | 0.45% | ||
| 91.83 | 6.358B | 0.35% | ||
| 56.56 | 5.241B | 0.40% |
Mutual Fund Opportunities
Name | Last Price | Net Assets | Expense Ratio | YTD Return |
|---|---|---|---|---|
| 216.29 | 45.706B | 0.29% | ||
| 91.20 | 45.706B | 0.29% | ||
| 133.63 | 20.002B | 0.10% | ||
| 93.67 | 14.487B | 0.80% | ||
| 93.40 | 14.487B | 0.80% |
Healthcare Research
Discover the Latest Analyst and Technical Research for This Sector
Daily – Vickers Top Insider Picks for 05/20/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Buyers & Sellers for 05/20/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover
In this edition, market underestimating margin recovery for pathology providers; potash prices poised for rebound; GTA 6's delay steals some shine from Take-Two earnings; and Globant, Fortrea Holdings, and Boralex.
Analyst Report: ConvaTec Group PLC
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 33% and 29% of total revenue, respectively. Continence care has become a slightly smaller business (21% of revenue) following the decision to exit the acute care market, and infusion sets contribute 17% of consolidated revenue.
RatingPrice Target